Your browser doesn't support javascript.
loading
Clinical outcomes of mild to moderate coronavirus disease 2019 patients treated with Regdanvimab in delta-variant outbreak: Retrospective cohort study.
Noh, Hyeong-Jun; Song, Jin Hwa; Ham, Sin Young; Park, Yeonkyung; Won, Ha-Kyeong; Kim, Soo Jung; Chung, Keun Bum; Kim, Choon Kwan; Ahn, Young Mee; Lee, Byoung-Jun; Kang, Hye-Rin.
Afiliación
  • Noh HJ; Division of Pulmonary and Allergy Medicine, Department of Internal Medicine, Veterans Health Service Medical Center, Seoul, Republic of Korea.
  • Song JH; Division of Pulmonary and Allergy Medicine, Department of Internal Medicine, Veterans Health Service Medical Center, Seoul, Republic of Korea.
  • Ham SY; Division of Infectious Disease, Department of Internal Medicine, Veterans Health Service Medical Center, Seoul, Republic of Korea.
  • Park Y; Division of Pulmonary and Allergy Medicine, Department of Internal Medicine, Veterans Health Service Medical Center, Seoul, Republic of Korea.
  • Won HK; Division of Pulmonary and Allergy Medicine, Department of Internal Medicine, Veterans Health Service Medical Center, Seoul, Republic of Korea.
  • Kim SJ; Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Kangnam Sacred Heart Hospital, Seoul, Republic of Korea.
  • Chung KB; Division of Pulmonary and Allergy Medicine, Department of Internal Medicine, Veterans Health Service Medical Center, Seoul, Republic of Korea.
  • Kim CK; Division of Infectious Disease, Department of Internal Medicine, Veterans Health Service Medical Center, Seoul, Republic of Korea.
  • Ahn YM; Division of Pulmonary and Allergy Medicine, Department of Internal Medicine, Veterans Health Service Medical Center, Seoul, Republic of Korea.
  • Lee BJ; Division of Pulmonary and Allergy Medicine, Department of Internal Medicine, Veterans Health Service Medical Center, Seoul, Republic of Korea.
  • Kang HR; Division of Pulmonary and Allergy Medicine, Department of Internal Medicine, Veterans Health Service Medical Center, Seoul, Republic of Korea.
Medicine (Baltimore) ; 102(45): e35987, 2023 Nov 10.
Article en En | MEDLINE | ID: mdl-37960790
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / COVID-19 Idioma: En Revista: Medicine (Baltimore) Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / COVID-19 Idioma: En Revista: Medicine (Baltimore) Año: 2023 Tipo del documento: Article